Making Integrated Care Work

Contact Us: 202.684.7457

SAMHSA-HRSA Center for Integrated Health Solutions

View Menu
Glossary
Facebook Twitter Listserve Ask a Question Email

Project ECHO Technical Assistance Initiative

The SAMHSA-HRSA Center for Integrated Health Solutions (CIHS) sponsored 10 HRSA-funded community health centers in January 2016 to participate in a 12-month learning community. This project aimed to improve the providers’ ability to provide medication and other services to treat opioid dependence. The learning community was run by Community Health Centers’ Inc. (CHC) Weitzman Institute using the Project ECHO (Extension for Community Health Outcomes) collaborative learning model.

Key Program Outcomes

CIHS tracked the progress of the 10 participating health centers to assess how Project ECHO supported the adoption of services and supports for opioid dependence.

The charts below highlight key metrics reported every three months over the 12-month period. Numbers in parentheses are baseline numbers provided by participating organizations in their original application.

Increased Services
Patient/Organizational Measure January – April May – August September – December Project Total
Number of patients screened for substance use 13,557 patients 16,853 patients 12,382 patients 42,792 patients
Number of patients screened positive for opioid misuse or dependence 1,461 patients 2,305 patients 1,390 patients 5,156 patients
Number of patients receiving buprenorphine treatment for opioid dependence 227 patients 300 patients 423 patients (366) 950 patients
Increased use of buprenorphine treatment for opioid dependence 

The number of patients receiving buprenorphine increased by 86% from the first three months to the final three months of the project.

Added Workforce/Policy Measures
Workforce/Policy Measures Total
Number of non-prescribing staff trained in MAT (18) 113 staff
Number of prescribing (DATA waivered) staff trained in MAT (21) 75 staff
Number of doctors on staff receiving buprenorphine (DATA) waiver 48 staff
Number of organizational-level policy changes specific to substance use/MAT completed 40 policies
Number of formal/informal agreements developed with outside substance use treatment providers or prescribers 40 agreements
Number of internal training, TA and dissemination activities related to substance abuse 102 activities

Conclusion

Based on the data collected, the technical assistance provided by Project ECHO resulted in practice change in the areas of clinical, operational and workforce for participating organizations. As shown in the above charts, this technical assistance lead to a significant increase in the number of patients treated for opioid use with buprenorphine and significant increases in staff members trained in MAT. Providers were overall satisfied with their participation with the Project ECHO initiative and reported that Project ECHO continues to be a useful tool to support their efforts to increase use of buprenorphine treatment for opioid abuse.

For more information on Project ECHO, contact Aaron Williams, Senior Director of Training and Technical Assistance for Substance Use at CIHS, at AaronW@TheNationalCouncil.org or at 202.684.7462

For more information on integrating medication assisted treatment into your practice, visit our MAT Overview page. 

Call Our Helpline: 202.684.7457

The SAMHSA-HRSA Center for Integrated Health Solutions (CIHS) sponsored 10 HRSA-funded community health centers in January 2016 to participate in a 12-month learning community. This project aimed to improve the providers’ ability to provide medication and other services to treat opioid dependence. The learning community was run by Community Health Centers’ Inc. (CHC) Weitzman Institute using the Project ECHO (Extension for Community Health Outcomes) collaborative learning model.

Key Program Outcomes

CIHS tracked the progress of the 10 participating health centers to assess how Project ECHO supported the adoption of services and supports for opioid dependence.

The charts below highlight key metrics reported every three months over the 12-month period. Numbers in parentheses are baseline numbers provided by participating organizations in their original application.

Increased Services
Patient/Organizational Measure January – April May – August September – December Project Total
Number of patients screened for substance use 13,557 patients 16,853 patients 12,382 patients 42,792 patients
Number of patients screened positive for opioid misuse or dependence 1,461 patients 2,305 patients 1,390 patients 5,156 patients
Number of patients receiving buprenorphine treatment for opioid dependence 227 patients 300 patients 423 patients (366) 950 patients
Increased use of buprenorphine treatment for opioid dependence 

The number of patients receiving buprenorphine increased by 86% from the first three months to the final three months of the project.

Added Workforce/Policy Measures
Workforce/Policy Measures Total
Number of non-prescribing staff trained in MAT (18) 113 staff
Number of prescribing (DATA waivered) staff trained in MAT (21) 75 staff
Number of doctors on staff receiving buprenorphine (DATA) waiver 48 staff
Number of organizational-level policy changes specific to substance use/MAT completed 40 policies
Number of formal/informal agreements developed with outside substance use treatment providers or prescribers 40 agreements
Number of internal training, TA and dissemination activities related to substance abuse 102 activities

Conclusion

Based on the data collected, the technical assistance provided by Project ECHO resulted in practice change in the areas of clinical, operational and workforce for participating organizations. As shown in the above charts, this technical assistance lead to a significant increase in the number of patients treated for opioid use with buprenorphine and significant increases in staff members trained in MAT. Providers were overall satisfied with their participation with the Project ECHO initiative and reported that Project ECHO continues to be a useful tool to support their efforts to increase use of buprenorphine treatment for opioid abuse.

For more information on Project ECHO, contact Aaron Williams, Senior Director of Training and Technical Assistance for Substance Use at CIHS, at AaronW@TheNationalCouncil.org or at 202.684.7462

For more information on integrating medication assisted treatment into your practice, visit our MAT Overview page. 

© 2011 NCBH, all rights reserved.
1400 K Street NW | Suite 400
Washington, D.C. 20005

Email: integration@thenationalcouncil.org

Phone: 202-684-7457